Gabelli & Co Investment Advisers’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,250
| Closed | -$290K | – | 254 |
|
|
2024
Q3 | $290K | Hold |
10,250
| – | – | 0.05% | 138 |
|
|
2024
Q2 | $196K | Buy |
10,250
+250
| +3% | +$4.78K | 0.03% | 191 |
|
|
2024
Q1 | $328K | Hold |
10,000
| – | – | 0.06% | 143 |
|
|
2023
Q4 | $330K | Hold |
10,000
| – | – | 0.06% | 142 |
|
|
2023
Q3 | $272K | Hold |
10,000
| – | – | 0.04% | 154 |
|
|
2023
Q2 | $303K | Hold |
10,000
| – | – | 0.05% | 143 |
|
|
2023
Q1 | $325K | Buy |
10,000
+2,000
| +25% | +$64.9K | 0.06% | 116 |
|
|
2022
Q4 | $225K | Hold |
8,000
| – | – | 0.05% | 178 |
|
|
2022
Q3 | $287K | Sell |
8,000
-3,000
| -27% | -$108K | 0.04% | 262 |
|
|
2022
Q2 | $338K | Buy |
+11,000
| New | +$338K | 0.04% | 265 |
|
|
2021
Q1 | – | Sell |
-10,000
| Closed | -$160K | – | 424 |
|
|
2020
Q4 | $160K | Hold |
10,000
| – | – | 0.02% | 261 |
|
|
2020
Q3 | $124K | Sell |
10,000
-8,300
| -45% | -$103K | 0.02% | 201 |
|
|
2020
Q2 | $130K | Sell |
18,300
-400
| -2% | -$2.84K | 0.03% | 159 |
|
|
2020
Q1 | $102K | Buy |
18,700
+7,500
| +67% | +$40.9K | 0.02% | 160 |
|
|
2019
Q4 | $101K | Sell |
11,200
-7,500
| -40% | -$67.6K | 0.01% | 176 |
|
|
2019
Q3 | $134K | Buy |
18,700
+3,200
| +21% | +$22.9K | 0.02% | 167 |
|
|
2019
Q2 | $123K | Buy |
15,500
+4,300
| +38% | +$34.1K | 0.01% | 172 |
|
|
2019
Q1 | $141K | Buy |
+11,200
| New | +$141K | 0.02% | 149 |
|
|
2018
Q2 | – | Sell |
-11,000
| Closed | -$157K | – | 162 |
|
|
2018
Q1 | $157K | Hold |
11,000
| – | – | 0.02% | 149 |
|
|
2017
Q4 | $135K | Sell |
11,000
-500
| -4% | -$6.14K | 0.02% | 154 |
|
|
2017
Q3 | $205K | Buy |
+11,500
| New | +$205K | 0.02% | 150 |
|